Other STEAP metalloreductases such as STEAP4 and STEAP1 linked with prostate cancer progression as shown in studies by Gomes et al. (2014) and Jin et al. (2015) can be targets for suppression and or inhibition for their role in prostate cancer progression using inhibitory ligands. Here, STEAP4 is linked to prostate cancer.